pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,774 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT834Endpoints640BioPharma Dive243onclive165BioSpace98Fierce Biotech96raps39globenewswire health28fda recalls
therapy area
allOncology5008Rare Disease855Cardiology803Hematology772Immunology736Psychiatry & CNS582Pulmonology
  • Pfizer earns positive Phase 3 in multiple myeloma; ICON overstated revenue
    Pfizer’s positive Phase 3 data in multiple myeloma: The company’s Elrexfio produced a “statistically significant and clinically meaningful improvement” in progression-free survival in patients with…
    Endpoints · 3mo ago↗ source
  • Infant formula largely safe from heavy metals, FDA finds
    FDA sampled 312 major infant formula brands and found low or undetectable levels of pesticide residue, PFAS, heavy metals and phthalates.
    STAT · 3mo ago↗ source
  • After Apellis deal, Biogen looks to fill early-stage pipeline
    Biogen is still looking at deals even after earmarking $5.6 billion to buy Apellis Pharmaceuticals earlier this month. “Most of what we're going to be focusing on is early-stage development and res…
    Endpoints
← prev
page 67 of 71
next →
24
fda press21
fda medwatch18
573
Vaccines517
Endocrinology & Metabolism293
Ophthalmology265
Infectious Disease253
Nephrology239
· 3mo ago
↗ source
  • AstraZeneca rekindles UK relationship, pledges £300M to expand
    AstraZeneca and the UK government are back in each other's good graces. AstraZeneca on Wednesday said it is lifting its UK investment pause, with a £300 million budget to finish construction of a n…
    Endpoints · 3mo ago↗ source
  • STAT+: A patent win for Pfizer and BridgeBio
    A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout
    STAT · 3mo ago↗ source
  • Chiesi signs $1.9B deal to acquire KalVista and its approved drug
    Chiesi is buying commercial biotech KalVista Pharmaceuticals for about $1.9 billion in an extension of the industry's vigorous spring shopping spree. The Italian pharma will pay $27 per share {$KAL…
    Endpoints · 3mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
    The FDA announced efforts to make clinical trials more efficient, starting by reviewing data in real time from trials conducted by AstraZeneca and Amgen
    STAT · 3mo ago↗ source
  • Should pharma be swinging bigger with AI? One top researcher wants to try
    RIO DE JANEIRO — Kyunghyun Cho says he's a free man once again. He makes that observation, semi-jokingly, while looking over countless rows of poster presentations on the sidelines of the Internati…
    Endpoints · 3mo ago↗ source
  • Food safety experts warn of USDA brain drain
    An autism advisory committee finally meets again, antipsychotics and dementia, and more health news from Morning Rounds
    STAT · 3mo ago↗ source
  • GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts
    GSK is expecting several key late-stage readouts this year and, if they do not succeed, the company could change its team structure, CEO Luke Miels said during its first-quarter earnings call with…
    Endpoints · 3mo ago↗ source
  • MPM has collected three China drugs for its ‘best of both worlds’ strategy
    MPM BioImpact, a leading biotech investor, is going all in on its strategy to take China-born drugs to the global stage. Over the past year, its portfolio company K2 Therapeutics has amassed three…
    Endpoints · 3mo ago↗ source
  • AstraZeneca cuts a couple of late-stage life-cycle trials after disappointing efficacy
    AstraZeneca said it had stopped several mid- and late-stage trials of some of its pipeline programs in the past few months, potentially limiting some of the life-cycle extensions it was hoping for.…
    Endpoints · 3mo ago↗ source
  • Opinion: Why alternative medicine can feel so much better than mainstream health care
    Modern medicine is about making people better — not necessarily making them feel good.
    STAT · 3mo ago↗ source
  • Opinion: The medical school nutrition blues
    “I don’t think anyone has the answers. But the conversation needs to start”: medical students on bringing a preventive mindset to medical education.
    STAT · 3mo ago↗ source
  • Opinion: STAT+: Did Kennedy just stack the deck on FDA oversight of peptides?
    RFK Jr. had long signaled that he was going to do something big on peptides. Now the moment has arrived.
    STAT · 3mo ago↗ source
  • New report shows some health equity wins. Experts fear they will be short-lived
    A report released Wednesday highlights successes in reducing health disparities in U.S. states between 2022 and 2024.
    STAT · 3mo ago↗ source
  • In first meeting, federal autism committee focuses on ‘profound autism’
    The committee met for the first time since Kennedy fired most of the committee’s scientific experts and replaced them with activists and advocates.
    STAT · 3mo ago↗ source
  • STAT+: Health system CEOs get off easy at Congressional hearing on affordability
    Committee members largely blamed the other party’s health care policies for driving U.S. health care prices to levels inaccessible to many Americans.
    STAT · 3mo ago↗ source
  • STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
    The AIDS advocacy group PrEP4All has sued the Trump administration over an undisclosed agreement with Gilead.
    STAT · 3mo ago↗ source
  • STAT+: FDA launches effort to speed up clinical trials, using AI
    Monitoring trials in real time may help shorten the time interval between trial phases.
    STAT · 3mo ago↗ source
  • Opinion: Healthcare or health care? Help STAT decide
    Should STAT use “healthcare” or “health care”? We want to hear from you.
    STAT · 3mo ago↗ source
  • FDA debuts plan to collect real-time clinical trial data
    The FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers access to the data as it flows in, the agency announced Tuesday. AstraZeneca…
    Endpoints · 3mo ago↗ source
  • The crown for healthcare admin tech is still up for grabs
    A few years in, admin tech is still reigning as the king of health tech funding. Startups using AI to tackle mundane administrative work in healthcare, such as follow-ups,
    Endpoints · 3mo ago↗ source
  • Pfizer delays patent cliff for blockbuster Vyndamax
    Pfizer is staving off Vyndamax competition for another two years. The drug, also known as tafamidis, is among Pfizer’s top three best-selling medicines and vaccines. Vyndamax is approved for a hear…
    Endpoints · 3mo ago↗ source
  • Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
    “For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the cloud as they occur,” writes FDA commissioner.
    STAT · 3mo ago↗ source